LabSolutions DISCOVER™ test represents a major advance in prenatal testing, providing accurate answers about fetal chromosomal health without the risks associated with invasive procedures.
The DISCOVER™ prenatal test is a simple and non-invasive blood test that screens for the most common chromosomal variations that can affect the health of your developing baby. The DISCOVER™ test is available for both singleton and twin pregnancies, and results are usually reported back to your healthcare provider within approximately two weeks.
The DISCOVER™ test offers parents-to-be the option to obtain important information about the health of their developing baby, quickly, accurately and with little to no risk to their pregnancy.
This screening test is usually indicated for pregnant women who meet any of the following criteria:
Results tell the provider whether or not trisomies 21, 18, 13 or sex chromosome abnormalities (if ordered) are highly likely to be present in pregnancy. In the case of a positive result, the provider will discuss what the results mean to your pregnancy as well as further testing options to consider.
Your test report will include one of three possible results for chromosomes 21, 18, and 13:
No Aneuploidy Detected—means the expected number of chromosomes was found.
Aneuploidy Detected—means too many or too few copies of one of the chromosomes have been identified. This can indicate a chromosome abnormality. Your provider may advise a diagnostic test for confirmation
In significantly rare cases, no result is possible. Your healthcare provider will discuss next steps with you.
With its superior technology, the DISCOVER™ test provides clinical evidence showing across-the-whole genome analysis in a real-world population. The performance of the DISCOVER™ prenatal test was evaluated in a major scientific study, which included more than 60 leading US medical research and teaching institutions.
